Transition of care from adolescence to early adulthood in severe asthmatic patients treated with omalizumab in real life
Langue
EN
Article de revue
Ce document a été publié dans
Erj Open Research. 2024-07-08, vol. 10, n° 4, p. 00976-2023
Résumé en anglais
Half of severely asthmatic adolescents treated with omalizumab transitioning to adulthood discontinue the treatment, suggesting insufficient asthma control. However, most of the other half have low rates of HCRU markers, ...Lire la suite >
Half of severely asthmatic adolescents treated with omalizumab transitioning to adulthood discontinue the treatment, suggesting insufficient asthma control. However, most of the other half have low rates of HCRU markers, their asthma being under control. https://bit.ly/49ixpxt.< Réduire
Unités de recherche